Overall, the study by Yan et al. (2013) in combination with other recent reports has provided novel insights into how misregulation of PAC1 alternative splicing could contribute to the risk of developing schizophrenia, not only by affecting embryonic neurogenesis, but also by impairing proliferation and differentiation of adult stem cells. The gene discussed is ADCYAP1R1; the disease is schizophrenia.